Peripheral T-Cell Lymphoma (PTCL NOS)
2 clinical trials · Condition
◉ Watch Peripheral T-Cell Lymphoma (PTCL NOS)
| Record | Firm | Date |
|---|---|---|
| Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma (NCT07535762) | Shanghai Jiao Tong University School of Medicine | 2026-03-30 |
| CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) (NCT04021082) | Portola Pharmaceuticals | 2019-11-15 |
Track Peripheral T-Cell Lymphoma (PTCL NOS) automatically
Every clearance here is in the API, with alerts when new ones post.